Issue 7, 2016

Antibodies as stratagems against cancer

Abstract

Antibodies have been in the frontline of anticancer research during the last few decades, since a number of different ways have been discovered to utilize them as parts or main components of anticancer drugs. Antibodies are used as the only component of some anticancer drugs, but they can also be conjugated with a variety of substances. Antibody engineering methods such as humanization, chimerization and Fc engineering are applied in order to modify their properties according to the requirements of anticancer drug application. Given the continuous advances in biology and informatics, the role of antibodies in anticancer treatment is expected to be prominent.

Graphical abstract: Antibodies as stratagems against cancer

Article information

Article type
Review Article
Submitted
20 Oct 2015
Accepted
11 Dec 2015
First published
11 Dec 2015

Mol. BioSyst., 2016,12, 2047-2055

Antibodies as stratagems against cancer

L. Papageorgiou, N. T. Cuong and D. Vlachakis, Mol. BioSyst., 2016, 12, 2047 DOI: 10.1039/C5MB00699F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements